These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33883451)

  • 1. Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease.
    Hemenway G; Frishman WH
    Cardiol Rev; 2022 Mar-Apr 01; 30(2):90-99. PubMed ID: 33883451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction.
    Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV
    J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
    Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
    Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
    Satish M; Agrawal DK
    Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
    Grebe A; Hoss F; Latz E
    Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
    Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
    J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy.
    Li Y; Zhang Y; Lu J; Yin Y; Xie J; Xu B
    J Cell Mol Med; 2021 Sep; 25(17):8087-8094. PubMed ID: 34312998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm.
    Takahashi M
    Circ J; 2021 Nov; 85(12):2129-2136. PubMed ID: 33883388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome as a key driver of vascular disease.
    Takahashi M
    Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
    Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
    Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
    Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
    EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
    Takahashi M
    Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity protects NLRP3 inflammasome-associated coronary vascular dysfunction in obese mice.
    Lee J; Lee Y; LaVoy EC; Umetani M; Hong J; Park Y
    Physiol Rep; 2018 Jun; 6(12):e13738. PubMed ID: 29932503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in Coronary Atherosclerosis and Its Therapeutic Implications.
    Montarello NJ; Nguyen MT; Wong DTL; Nicholls SJ; Psaltis PJ
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):347-362. PubMed ID: 33170943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway.
    Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasomes: a preclinical assessment of targeting in atherosclerosis.
    Stitham J; Rodriguez-Velez A; Zhang X; Jeong SJ; Razani B
    Expert Opin Ther Targets; 2020 Sep; 24(9):825-844. PubMed ID: 32757967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.